Mariner’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4M | Buy |
27,033
+9,021
| +50% | +$1.13M | ﹤0.01% | 1038 |
|
|
2025
Q1 | $1.99M | Sell |
18,012
-2,627
| -13% | -$291K | ﹤0.01% | 1252 |
|
|
2024
Q4 | $2.82M | Buy |
20,639
+3,857
| +23% | +$526K | ﹤0.01% | 1038 |
|
|
2024
Q3 | $1.93M | Sell |
16,782
-3,107
| -16% | -$358K | ﹤0.01% | 1207 |
|
|
2024
Q2 | $2.74M | Buy |
19,889
+395
| +2% | +$54.4K | 0.01% | 954 |
|
|
2024
Q1 | $2.69M | Buy |
19,494
+2,397
| +14% | +$331K | 0.01% | 968 |
|
|
2023
Q4 | $2.25M | Buy |
17,097
+6,119
| +56% | +$806K | 0.01% | 1008 |
|
|
2023
Q3 | $1.24M | Buy |
10,978
+670
| +6% | +$75.4K | ﹤0.01% | 1212 |
|
|
2023
Q2 | $972K | Buy |
10,308
+395
| +4% | +$37.2K | ﹤0.01% | 1331 |
|
|
2023
Q1 | $1M | Sell |
9,913
-684
| -6% | -$69.2K | ﹤0.01% | 1274 |
|
|
2022
Q4 | $1.27M | Sell |
10,597
-1,183
| -10% | -$141K | ﹤0.01% | 1129 |
|
|
2022
Q3 | $1.25M | Buy |
11,780
+129
| +1% | +$13.7K | 0.01% | 956 |
|
|
2022
Q2 | $1.14M | Buy |
11,651
+855
| +8% | +$83.4K | ﹤0.01% | 864 |
|
|
2022
Q1 | $1.01M | Buy |
+10,796
| New | +$1.01M | ﹤0.01% | 927 |
|
|
2019
Q3 | – | Sell |
-2,637
| Closed | -$223K | – | 922 |
|
|
2019
Q2 | $223K | Sell |
2,637
-17
| -0.6% | -$1.44K | ﹤0.01% | 1006 |
|
|
2019
Q1 | $234K | Buy |
+2,654
| New | +$234K | ﹤0.01% | 907 |
|